معرفی
Charles Davis serves as the James E. Bobb Professor and Vice Chair for Clinical Affairs in the Department of Orthopaedics and Rehabilitation, and Chief of the Division of Hip and Knee Joint Arthroplasty. Board-certified in adult reconstruction by the American Board of Orthopaedic Surgery since 2000, his clinical expertise focuses on complex joint replacement procedures.
Education:
- Fellowship, Mayo Graduate School of Medicine (1996 → 1997)
- Residency, Mayo Graduate School of Medicine (1992 → 1996)
- Internship, Mayo Graduate School of Medicine (1991 → 1992)
Research Focus: Dr. Davis specializes in advancing total joint arthroplasty through rigorous investigation of implant design, surgical techniques, and patient-centered outcomes. His work addresses critical challenges in hip and knee replacement, including implant fixation methodologies (cemented vs. cementless), anesthetic impacts on mental health recovery, and radiographic detection of implant failure. This research directly supports UN Sustainable Development Goals by improving surgical accessibility and postoperative well-being.
Publication Trends: Recent work demonstrates a shift toward comparative effectiveness studies, with emphasis on patient-reported outcomes and process optimization in arthroplasty. His 2024-2025 publications analyze implant design variations in knee replacement while establishing that mental health improvements after hip surgery transcend anesthetic choices, highlighting patient factors as primary drivers of recovery.
Awards and Recognition:
- AAOS Achievement Award (2019)
- Humanitarian Orthopaedist Award Presented in Memory of Lisa Pellegrini (2019)
- Steven and Sharon Baron Leadership Award (2019)
- HCAHPS Inpatient Dean's List for Extraordinary Patient Satisfaction (2018)
Academic Contributions: As Vice Chair for Clinical Affairs, Dr. Davis shapes departmental strategy while maintaining active surgical practice. His fingerprint analysis confirms deep specialization in hip/knee arthroplasty (100% Total Knee Arthroplasty, 47% Hip), with significant contributions to implant technology and surgical outcomes research. No information regarding student advising or grant funding is available in the provided text.
